Promega's Cookie Policy

We use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we won’t set them unless you accept them. To find out more about cookies and how to manage cookies, read our Cookie Policy.

HiBiT Targeted Cell Killing (TCK) Bioassays For Characterization and Potency Testing

Part # PS577

Abstract

Gopal Krishnan, Ph.D., Julia Gilden, Ph.D., Brock Binkowski, Ph.D., Nicholas J. Hess, Ph.D., Pete Stecha, M.S., Aileen Paguio, M.S., Marjeta Urh, Ph.D., Mei Cong, Ph.D.
Promega Corporation, 2800 Woods Hollow Road, Madison WI 53711

Effector cell-mediated killing of TCKCells leads to release of the HiBiT fusion protein into the extracellular medium. Cell impermeable LgBiT and Furimazine substrate (Fz) are added as components of the Bio-Glo-NB TCK Reagent. HiBiT complementation with LgBiT generates NanoBiT® luciferase, a bright, luminescent enzyme.